Pediatrics
News from the FDA/CDC
Ustekinumab becomes second biologic approved for PsA in kids
The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to...
News from the FDA/CDC
FDA approves belimumab for children with lupus nephritis
Children with lupus-related kidney damage can now receive the B cell–reducing therapy that adults with lupus nephritis have been able to get for...
Latest News
Think of pediatric morphea as a systemic, chronic disease, expert advises
Predictors of poor quality of life include female sex and involvement of hands and feet.
From the Journals
Uveitis in juvenile arthritis patients persists into midlife
Data suggest the need for lifelong ophthalmic checkups for JIA patients diagnosed with uveitis.
Feature
No more ‘escape hatch’: Post Roe, new worries about meds linked to birth defects
Physicians fear that women won’t get the best treatments or will face dangerous risks.
Latest News
Pandemic public health measures may have mitigated Kawasaki disease
Cohort study data suggest that actions to reduce the spread of COVID-19 also reduced exposure to Kawasaki disease triggers.
Conference Coverage
Biomarkers may help to predict persistent oligoarticular JIA
Analysis of a small group of samples revealed that the selected biomarkers more accurately predicted persistent disease than disease likely to...
Guidelines
Updated pediatric uveitis recommendations advise on expanded treatment options
The recommendations represent an update of 2018 consensus-based recommendations from the SHARE Initiative and the 2019 American College of...
Conference Coverage
‘Encouraging’ results of baricitinib in juvenile idiopathic arthritis
Phase 3 trial results of baricitinib in juvenile idiopathic arthritis (JIA) show the JAK inhibitor increases time to flare and reduces frequency...
Feature
Abortion debate may affect Rx decisions for pregnant women
Enactment of abortion restrictions in a growing number of states could have a chilling effect on therapy regimens in pregnant women and their...
Conference Coverage
Pfizer COVID vaccine performs well in youth with rheumatic diseases
Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.